Get started
Author

Srikanth Pendyala

NADPH Oxidase Is Required for the Sensory Plasticity of the Carotid Body by Chronic Intermittent Hypoxia
2009 · Y.- J. Peng, J. Nanduri, et al. · Journal of Neuroscience · 197
PDF
Role of Nox4 and Nox2 in Hyperoxia-Induced Reactive Oxygen Species Generation and Migration of Human Lung Endothelial Cells
2008 · Srikanth Pendyala, Irina A Gorshkova, et al. · Antioxidants and Redox Signaling · 182
NOX Enzymes and Pulmonary Disease
2009 · Brian Griffith, Srikanth Pendyala, et al. · Antioxidants and Redox Signaling · 157
Oxygen Sensing by Primary Cardiac Fibroblasts
2003 · Sashwati Roy, Savita Khanna, et al. · Circulation Research · 145
Redox regulation of Nox proteins
2010 · Srikanth Pendyala, Viswanathan Natarajan · Respiratory Physiology & Neurobiology · 126
Regulation of NADPH Oxidase in Vascular Endothelium: The Role of Phospholipases, Protein Kinases, and Cytoskeletal Proteins
2008 · Srikanth Pendyala, Peter V. Usatyuk, et al. · Antioxidants and Redox Signaling · 123
Protection of LPS-Induced Murine Acute Lung Injury by Sphingosine-1-Phosphate Lyase Suppression
2010 · Yutong Zhao, Irina A. Gorshkova, et al. · American Journal of Respiratory Cell and Molecular Biology · 118
Particulate Matter Disrupts Human Lung Endothelial Barrier Integrity via ROS- and p38 MAPK–Dependent Pathways
2009 · Ting Wang, Eddie T. Chiang, et al. · American Journal of Respiratory Cell and Molecular Biology · 111
Nrf2 regulates hyperoxia-induced Nox4 expression in human lung endothelium: Identification of functional antioxidant response elements on the Nox4 promoter
2011 · Srikanth Pendyala, Jaideep Moitra, et al. · Free Radical Biology and Medicine · 101
Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition
2008 · Weiguo Chen, Srikanth Pendyala, et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 100
FoxM1 mediates the progenitor function of type II epithelial cells in repairing alveolar injury induced by Pseudomonas aeruginosa
2011 · Yuru Liu, Ruxana T. Sadikot, et al. · The Journal of Experimental Medicine · 98
Targeting sphingosine kinase 1 attenuates bleomycin‐induced pulmonary fibrosis
2013 · Long Shuang Huang, Evgeny Berdyshev, et al. · The FASEB Journal · 93
Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma
2009 · Yutong Zhao, Jiankun Tong, et al. · Respiratory Research · 67
PDF
Regulation of Hyperoxia-induced NADPH Oxidase Activation in Human Lung Endothelial Cells by the Actin Cytoskeleton and Cortactin
2007 · Peter V. Usatyuk, Lewis H. Romer, et al. · Journal of Biological Chemistry · 65
Protein Kinase C-ϵ Regulates Sphingosine 1-Phosphate-mediated Migration of Human Lung Endothelial Cells through Activation of Phospholipase D2, Protein Kinase C-ζ, and Rac1
2008 · Irina Gorshkova, Donghong He, et al. · Journal of Biological Chemistry · 59
PDF
Sphingosine Kinase 1 Deficiency Confers Protection against Hyperoxia-Induced Bronchopulmonary Dysplasia in a Murine Model
2013 · Anantha Harijith, Srikanth Pendyala, et al. · American Journal Of Pathology · 52
PDF
Novel Role for Non-muscle Myosin Light Chain Kinase (MLCK) in Hyperoxia-induced Recruitment of Cytoskeletal Proteins, NADPH Oxidase Activation, and Reactive Oxygen Species Generation in Lung Endothelium
2012 · Peter V. Usatyuk, Patrick A. Singleton, et al. · Journal of Biological Chemistry · 50
PDF
Hyperoxia-induced p47phoxactivation and ROS generation is mediated through S1P transporter Spns2, and S1P/S1P1&2signaling axis in lung endothelium
2016 · Anantha Harijith, Srikanth Pendyala, et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 39
PDF
Dynamin 2 and c-Abl Are Novel Regulators of Hyperoxia-mediated NADPH Oxidase Activation and Reactive Oxygen Species Production in Caveolin-enriched Microdomains of the Endothelium
2009 · Patrick A. Singleton, Srikanth Pendyala, et al. · Journal of Biological Chemistry · 36
PDF
Revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy: Safety and tolerability results of a 52-week phase 3 trial in moderate to very severe chronic obstructive pulmonary disease
2019 · James F. Donohue, Edward Kerwin, et al. · Respiratory Medicine · 35
Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate
2019 · Donald A. Mahler, Jill A. Ohar, et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · 35
Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical Trials
2019 · Gary T. Ferguson, Gregory Feldman, et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · 30
PDF
Coronin 1B Regulates S1P-Induced Human Lung Endothelial Cell Chemotaxis: Role of PLD2, Protein Kinase C and Rac1 Signal Transduction
2013 · Peter V. Usatyuk, Michael Burns, et al. · PLoS ONE · 20
PDF
Sphingosine Kinase 1 Is Required for Mesothelioma Cell Proliferation: Role of Histone Acetylation
2012 · Satish Kalari, Nagabhushan Moolky, et al. · PLoS ONE · 18
PDF
Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)
2019 · James F. Donohue, Edward Kerwin, et al. · Respiratory Research · 16
PDF
Works count: 67
Citation count: 2,128
H-index: 22
I10-index: 27
Year
Topic
Type